-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In 2020, the term metabolic dysfunction-related fatty liver (MAFLD) was proposed and replaced non-alcoholic fatty liver (NAFLD)
.
Recently, a research article was published in the Journal of Clinical Endocrinology & Metabolism, an authoritative journal in the field of endocrine and metabolic diseases.
Non-alcoholic fatty liver
A total of 6873 subjects were included in the study, and the follow-up time was 4.
6 years
MAFLD is associated with higher diabetes (risk ratio [RR] of 2.
08, 95% CI of 1.
The change from NAFLD to MAFLD has little effect on its association with diabetes, CKD and CVD
Original source:
Yebei Liang.
et al.
Association of MAFLD with diabetes, chronic kidney disease, and cardiovascular disease: a 4.
6-year cohort study in China .
JCEM.
Association of MAFLD with diabetes, chronic kidney disease, and cardiovascular disease: a 4.
6-year cohort study in China in this message